The VA likely reopened your claim to evaluate the residuals of your service-connected testicular cancer, as the initial grant is often for the active malignancy (diagnostic code 7528) rated at 100% under 38 CFR 4.30, but requires a future examination to assign a permanent rating for any chronic residuals—such as hormone replacement therapy, nerve damage, or psychological effects—which are separately evaluated under codes like 7529 (orchitectomy, one or both) or linked conditions like erectile dysfunction (code 7522). This process is governed by 38 CFR 3.105(e) and 3.327, and the VA must schedule an examination to assess these residuals; your rating cannot be reduced without a showing of sustained improvement under 38 CFR 3.344. Your actionable next steps are to: 1) obtain and carefully review the Decision Letter for the specific reason for reopening, 2) prepare for the VA examination by gathering private medical records detailing all ongoing symptoms and complications, and consider submitting a DBQ completed by your specialist, and 3) proactively file for secondary conditions (e.g., scars, mental health, or hypogonadism) if not already claimed, as established in *Shedden v. Principi*, which requires the VA to consider all downstream effects. If the new proposed rating is unfavorable, you have the right to submit additional evidence and request a hearing before the final decision under 38 CFR 3.105(f).
*Disclaimer: This is educational information for claims assistance and is not legal or medical advice; for personal guidance, consult an accredited VA attorney or claims agent.*
Need a deeper analysis?
Our AI analyzes your specific situation against thousands of BVA decisions.
Analyze Your Claim Free